Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Subanesthetic esketamine doses for prevention of emergence agitation in pediatric tonsillectomy
ChiCTR2300071495Phase 4Not yet recruiting
- Sponsor
- Ya'an People's Hospital
- Start
- May 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of esketamine in Emergence agitation (EA) (2 arms), sponsored by Ya'an People's Hospital. Primary endpoint: Incidence of emergence agitation. Planned start May 2023; status: not yet recruiting.
02
Drugs
esketamine
03
Conditions
Emergence agitation (EA)
Beyond the preview
Go deeper on ChiCTR2300071495.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2300071495.